Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accent MicrocellNSE:ACCENTMIC +1.13%48 Return-on-Tangible-Asset is 15.95% as of Mar. 2026, which is 17% above its 10-year median of 13.62. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 48/100. The stock has 6 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Accent Microcell ranks better than 89.46% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Accent Microcell's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹439 Mil. Accent Microcell's average total tangible assets for the quarter that ended in Mar. 2026 was ₹2,750 Mil. Therefore, Accent Microcell's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 15.95%.
The historical rank and industry rank for Accent Microcell's Return-on-Tangible-Asset or its related term are showing as below:
NSE:ACCENTMIC'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.96 Med: 13.62 Max: 19.18
Current: 15.95
During the past 6 years, Accent Microcell's highest Return-on-Tangible-Asset was 19.18%. The lowest was 5.96%. And the median was 13.62%.
NSE:ACCENTMIC's Return-on-Tangible-Asset is ranked better than 89.46% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 2.96
vs NSE:ACCENTMIC: 15.95
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Accent Microcell Return-on-Tangible-Asset Related Terms
Accent Microcell Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Accent Microcell's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ACCENTMIC vs ZTS: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Accent Microcell's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 15.95% mean?
Accent Microcell (NSE:ACCENTMIC) has a Return-on-Tangible-Asset of 15.95% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Accent Microcell and its competitors. This is 17% above median its historical median of 13.62. Over the past decade, Accent Microcell's Return-on-Tangible-Asset has ranged from 5.96 to 19.18. According to the industry distribution chart, Accent Microcell ranks #106 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 10.5%.
Is Accent Microcell's Return-on-Tangible-Asset too high?
Accent Microcell's current Return-on-Tangible-Asset of 15.95% is 17% above median its 10-year median of 13.62. Over the past 10 years, this metric has ranged from a low of 5.96 to a high of 19.18. The Drug Manufacturers industry median Return-on-Tangible-Asset is 2.96. Accent Microcell's value of 15.95% is 438.9% above this industry median. Based on the distribution chart, Accent Microcell ranks #106 out of 1006 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Accent Microcell has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's Return-on-Tangible-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #106 out of 1006 companies for Return-on-Tangible-Asset. This places Accent Microcell in the top 11% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.96. Accent Microcell's value of 15.95% is 438.9% above this benchmark. Historically, Accent Microcell's own Return-on-Tangible-Asset has ranged from 5.96 to 19.18 over the past decade. While the company's 10-year median is 13.62 vs. the industry median of 2.96, Accent Microcell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 2.96, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current Return-on-Tangible-Asset of 15.95% is 438.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current Return-on-Tangible-Asset is 15.95%, which is 17% above median its own 10-year median of 13.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current Return-on-Tangible-Asset of 15.95%. The current Return-on-Tangible-Asset is 15.95%, which is 17% above median its 10-year median of 13.62 and 438.9% above the Drug Manufacturers industry median of 2.96. Accent Microcell's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current Return-on-Tangible-Asset is 15.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
48GF Score
Get the complete analysis for NSE:ACCENTMIC
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 
